Posted by Michael Wonder on 15 Dec 2017
FDA targets insulin for increased competition to lower prices
16 December 2017 - Prices of the diabetes medicine have risen 270%.
The FDA will add insulin, a life-saving drug used by millions of diabetics, to its campaign to add generic competitors to brand-name products the agency believes are part of the U.S.’s medical cost problem.
